Company / Current Assets
Decoy Therapeutics Inc. Current Assets History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$14.5M
FY2022
5-year range
$4.7M / $30.2M
FY2018-FY2022
Trend
-51.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $16M to $15M over the past 2 years.
Based on SEC 10-K filings.
$15M in FY2022 with a 5-year CAGR of -15.9%.
Declined from $16M to $15M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +45.7%
- 5-Year CAGR
- -15.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -15.9%, indicating a declining trend.
- In FY2022, current assets decreased 51.9% year-over-year.
- Peak current assets was recorded in FY2016.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $14.5M | -51.9% |
| FY2021 | $30.2M | +90.9% |
| FY2020 | $15.8M | +236.5% |
| FY2019 | $4.7M | -54.5% |
| FY2018 | $10.3M | -70.1% |
| FY2017 | $34.5M | -44.7% |
| FY2016 | $62.5M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026